ID   ASPG_HUMAN              Reviewed;         346 AA.
AC   P20933; B2R7H2; D3DP47; Q4W5Q2; Q6FHN6; Q9UCK6; Q9UCK7; Q9UCK8;
DT   01-FEB-1991, integrated into UniProtKB/Swiss-Prot.
DT   09-FEB-2010, sequence version 2.
DT   10-MAY-2017, entry version 175.
DE   RecName: Full=N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase;
DE            EC=3.5.1.26;
DE   AltName: Full=Aspartylglucosaminidase;
DE   AltName: Full=Glycosylasparaginase;
DE   AltName: Full=N4-(N-acetyl-beta-glucosaminyl)-L-asparagine amidase;
DE   Contains:
DE     RecName: Full=Glycosylasparaginase alpha chain;
DE   Contains:
DE     RecName: Full=Glycosylasparaginase beta chain;
DE   Flags: Precursor;
GN   Name=AGA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT SER-149.
RX   PubMed=2401370; DOI=10.1016/0014-5793(90)81211-6;
RA   Fisher K.J., Tollersrud O.-K., Aronson N.N. Jr.;
RT   "Cloning and sequence analysis of a cDNA for human
RT   glycosylasparaginase. A single gene encodes the subunits of this
RT   lysosomal amidase.";
RL   FEBS Lett. 269:440-444(1990).
RN   [2]
RP   ERRATUM.
RX   PubMed=2265705;
RA   Fisher K.J., Tollersrud O.-K., Aronson N.N. Jr.;
RL   FEBS Lett. 276:232-232(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 206-235, ACTIVATION BY
RP   CLEAVAGE, CATALYTIC ACTIVITY, VARIANTS SER-149; AGU GLN-161 AND
RP   SER-163, AND CHARACTERIZATION OF VARIANT AGU SER-163.
RC   TISSUE=Fetal liver;
RX   PubMed=1703489;
RA   Ikonen E., Baumann M., Groen K., Syvaenen A.-C., Enomaa N., Halila R.,
RA   Aula P., Peltonen L.;
RT   "Aspartylglucosaminuria: cDNA encoding human aspartylglucosaminidase
RT   and the missense mutation causing the disease.";
RL   EMBO J. 10:51-58(1991).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT SER-149.
RX   PubMed=1840528; DOI=10.1016/0014-5793(91)81027-6;
RA   Park H., Fisher K.J., Aronson N.N. Jr.;
RT   "Genomic structure of human lysosomal glycosylasparaginase.";
RL   FEBS Lett. 288:168-172(1991).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA], AUTOCATALYTIC CLEAVAGE, CATALYTIC
RP   ACTIVITY, AND VARIANTS SER-149; AGU GLN-161 AND SER-163.
RX   PubMed=1904874;
RA   Fisher K.J., Aronson N.N. Jr.;
RT   "Characterization of the mutation responsible for
RT   aspartylglucosaminuria in three Finnish patients. Amino acid
RT   substitution Cys163-->Ser abolishes the activity of lysosomal
RT   glycosylasparaginase and its conversion into subunits.";
RL   J. Biol. Chem. 266:12105-12113(1991).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 24-45; 47-60; 67-84;
RP   98-120; 123-190; 206-314 AND 320-343, AND VARIANTS AGU GLN-161 AND
RP   SER-163.
RX   PubMed=2011603; DOI=10.1073/pnas.88.7.2941;
RA   Mononen I., Heisterkamp N., Kaartinen V., Williams J.C.,
RA   Yates J.R. III, Griffin P.R., Hood L.E., Groffen J.;
RT   "Aspartylglycosaminuria in the Finnish population: identification of
RT   two point mutations in the heavy chain of glycoasparaginase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:2941-2945(1991).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT SER-149.
RC   TISSUE=Urinary bladder;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT SER-149.
RA   Halleck A., Ebert L., Mkoundinya M., Schick M., Eisenstein S.,
RA   Neubert P., Kstrang K., Schatten R., Shen B., Henze S., Mar W.,
RA   Korn B., Zuo D., Hu Y., LaBaer J.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT SER-149.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT SER-149.
RC   TISSUE=Ovary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [12]
RP   PROTEIN SEQUENCE OF 25-44 AND 206-231, AND GLYCOSYLATION AT ASN-38.
RC   TISSUE=Liver;
RX   PubMed=1281977; DOI=10.1042/bj2881005;
RA   Rip J.W., Coulter-Mackie M.B., Rupar C.A., Gordon B.A.;
RT   "Purification and structure of human liver aspartylglucosaminidase.";
RL   Biochem. J. 288:1005-1010(1992).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15]
RP   CLEAVAGE OF SIGNAL PEPTIDE [LARGE SCALE ANALYSIS] AFTER CYS-23, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 24-185 IN COMPLEX WITH
RP   ASPARTIC ACID, SUBUNIT, ACTIVE SITE, GLYCOSYLATION AT ASN-38 AND
RP   ASN-308, AND DISULFIDE BONDS.
RX   PubMed=8846222; DOI=10.1038/nsb1295-1102;
RA   Oinonen C., Tikkanen R., Rouvinen J., Peltonen L.;
RT   "Three-dimensional structure of human lysosomal
RT   aspartylglucosaminidase.";
RL   Nat. Struct. Biol. 2:1102-1108(1995).
RN   [17]
RP   REVIEW ON AGU VARIANTS.
RX   PubMed=1301945; DOI=10.1002/humu.1380010503;
RA   Ikonen E., Peltonen L.;
RT   "Mutations causing aspartylglucosaminuria (AGU): a lysosomal
RT   accumulation disease.";
RL   Hum. Mutat. 1:361-365(1992).
RN   [18]
RP   VARIANT AGU PRO-72.
RX   PubMed=8776587; DOI=10.1093/hmg/5.6.737;
RA   Peltola M., Tikkanen R., Peltonen L., Jalanko A.;
RT   "Ser72-->Pro active-site disease mutation in human lysosomal
RT   aspartylglucosaminidase: abnormal intracellular processing and
RT   evidence for extracellular activation.";
RL   Hum. Mol. Genet. 5:737-743(1996).
RN   [19]
RP   VARIANTS AGU GLU-100 AND SER-135.
RX   PubMed=9137882;
RA   Laitinen A., Hietala M., Haworth J.C., Schroeder M.L., Seargeant L.E.,
RA   Greenberg C.R., Aula P.;
RT   "Two novel mutations in a Canadian family with aspartylglucosaminuria
RT   and early outcome post bone marrow transplantation.";
RL   Clin. Genet. 51:174-178(1997).
RN   [20]
RP   VARIANTS AGU LEU-12; ARG-252; GLU-252 AND ILE-257.
RX   PubMed=11309371; DOI=10.1093/hmg/10.9.983;
RA   Saarela J., Laine M., Oinonen C., Schantz C., Jalanko A., Rouvinen J.,
RA   Peltonen L.;
RT   "Molecular pathogenesis of a disease: structural consequences of
RT   aspartylglucosaminuria mutations.";
RL   Hum. Mol. Genet. 10:983-995(2001).
CC   -!- FUNCTION: Cleaves the GlcNAc-Asn bond which joins oligosaccharides
CC       to the peptide of asparagine-linked glycoproteins.
CC   -!- CATALYTIC ACTIVITY: N(4)-(beta-N-acetyl-D-glucosaminyl)-L-
CC       asparagine + H(2)O = N-acetyl-beta-D-glucosaminylamine + L-
CC       aspartate. {ECO:0000269|PubMed:1703489,
CC       ECO:0000269|PubMed:1904874}.
CC   -!- SUBUNIT: Heterotetramer of two alpha and two beta chains arranged
CC       as a dimer of alpha/beta heterodimers.
CC       {ECO:0000269|PubMed:8846222}.
CC   -!- SUBCELLULAR LOCATION: Lysosome.
CC   -!- PTM: Cleaved into an alpha and beta chain by autocatalysis; this
CC       activates the enzyme. The N-terminal residue of the beta subunit
CC       is responsible for the nucleophile hydrolase activity.
CC   -!- DISEASE: Aspartylglucosaminuria (AGU) [MIM:208400]: An inborn
CC       lysosomal storage disease causing excess accumulation of
CC       glycoasparagine in the body tissues and its increased excretion in
CC       urine. Clinical features include mild to severe mental retardation
CC       manifesting from the age of two, coarse facial features and mild
CC       connective tissue abnormalities. {ECO:0000269|PubMed:11309371,
CC       ECO:0000269|PubMed:1703489, ECO:0000269|PubMed:1904874,
CC       ECO:0000269|PubMed:2011603, ECO:0000269|PubMed:8776587,
CC       ECO:0000269|PubMed:9137882}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the Ntn-hydrolase family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X55762; CAA39288.1; -; mRNA.
DR   EMBL; X55330; CAA39029.1; -; mRNA.
DR   EMBL; U21281; AAB60655.1; -; Genomic_DNA.
DR   EMBL; U21273; AAB60655.1; JOINED; Genomic_DNA.
DR   EMBL; U21274; AAB60655.1; JOINED; Genomic_DNA.
DR   EMBL; U21275; AAB60655.1; JOINED; Genomic_DNA.
DR   EMBL; U21277; AAB60655.1; JOINED; Genomic_DNA.
DR   EMBL; U21278; AAB60655.1; JOINED; Genomic_DNA.
DR   EMBL; U21279; AAB60655.1; JOINED; Genomic_DNA.
DR   EMBL; U21280; AAB60655.1; JOINED; Genomic_DNA.
DR   EMBL; X61959; CAA43958.1; -; Genomic_DNA.
DR   EMBL; M64073; AAA35903.1; -; mRNA.
DR   EMBL; M64075; AAA35904.1; ALT_SEQ; mRNA.
DR   EMBL; M64076; AAA35905.1; ALT_SEQ; mRNA.
DR   EMBL; M60808; AAA35901.1; -; mRNA.
DR   EMBL; M60809; AAA35902.1; -; mRNA.
DR   EMBL; AK312982; BAG35819.1; -; mRNA.
DR   EMBL; CR541715; CAG46516.1; -; mRNA.
DR   EMBL; AC078881; AAY40915.1; -; Genomic_DNA.
DR   EMBL; AC027627; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471056; EAX04714.1; -; Genomic_DNA.
DR   EMBL; CH471056; EAX04715.1; -; Genomic_DNA.
DR   EMBL; BC012392; AAH12392.1; -; mRNA.
DR   CCDS; CCDS3829.1; -.
DR   PIR; S11343; MUHUGD.
DR   RefSeq; NP_000018.2; NM_000027.3.
DR   RefSeq; NP_001165459.1; NM_001171988.1.
DR   UniGene; Hs.207776; -.
DR   PDB; 1APY; X-ray; 2.00 A; A/C=24-185, B/D=206-346.
DR   PDB; 1APZ; X-ray; 2.30 A; A/C=24-185, B/D=206-346.
DR   PDBsum; 1APY; -.
DR   PDBsum; 1APZ; -.
DR   ProteinModelPortal; P20933; -.
DR   SMR; P20933; -.
DR   BioGrid; 106683; 8.
DR   IntAct; P20933; 2.
DR   STRING; 9606.ENSP00000264595; -.
DR   BindingDB; P20933; -.
DR   MEROPS; T02.001; -.
DR   iPTMnet; P20933; -.
DR   PhosphoSitePlus; P20933; -.
DR   BioMuta; AGA; -.
DR   DMDM; 288558804; -.
DR   EPD; P20933; -.
DR   MaxQB; P20933; -.
DR   PaxDb; P20933; -.
DR   PeptideAtlas; P20933; -.
DR   PRIDE; P20933; -.
DR   DNASU; 175; -.
DR   Ensembl; ENST00000264595; ENSP00000264595; ENSG00000038002.
DR   GeneID; 175; -.
DR   KEGG; hsa:175; -.
DR   UCSC; uc003iuu.3; human.
DR   CTD; 175; -.
DR   DisGeNET; 175; -.
DR   GeneCards; AGA; -.
DR   H-InvDB; HIX0004652; -.
DR   HGNC; HGNC:318; AGA.
DR   HPA; HPA031415; -.
DR   HPA; HPA031417; -.
DR   MalaCards; AGA; -.
DR   MIM; 208400; phenotype.
DR   MIM; 613228; gene.
DR   neXtProt; NX_P20933; -.
DR   OpenTargets; ENSG00000038002; -.
DR   Orphanet; 93; Aspartylglucosaminuria.
DR   PharmGKB; PA24615; -.
DR   eggNOG; KOG1593; Eukaryota.
DR   eggNOG; COG1446; LUCA.
DR   GeneTree; ENSGT00530000063034; -.
DR   HOVERGEN; HBG004289; -.
DR   InParanoid; P20933; -.
DR   KO; K01444; -.
DR   OMA; KFFGAVI; -.
DR   OrthoDB; EOG091G0L36; -.
DR   PhylomeDB; P20933; -.
DR   TreeFam; TF300756; -.
DR   BioCyc; MetaCyc:HS00528-MONOMER; -.
DR   BRENDA; 3.5.1.26; 2681.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   SABIO-RK; P20933; -.
DR   ChiTaRS; AGA; human.
DR   EvolutionaryTrace; P20933; -.
DR   GeneWiki; Aspartylglucosaminidase; -.
DR   GenomeRNAi; 175; -.
DR   PMAP-CutDB; P20933; -.
DR   PRO; PR:P20933; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000038002; -.
DR   CleanEx; HS_AGA; -.
DR   ExpressionAtlas; P20933; baseline and differential.
DR   Genevisible; P20933; HS.
DR   GO; GO:0035578; C:azurophil granule lumen; TAS:Reactome.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:0005764; C:lysosome; IDA:UniProtKB.
DR   GO; GO:0003948; F:N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity; IDA:UniProtKB.
DR   GO; GO:0008233; F:peptidase activity; IEA:UniProtKB-KW.
DR   GO; GO:0043621; F:protein self-association; IEA:Ensembl.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0006517; P:protein deglycosylation; IDA:UniProtKB.
DR   GO; GO:0051604; P:protein maturation; IEA:Ensembl.
DR   InterPro; IPR029055; Ntn_hydrolases_N.
DR   InterPro; IPR000246; Peptidase_T2.
DR   PANTHER; PTHR10188; PTHR10188; 1.
DR   Pfam; PF01112; Asparaginase_2; 1.
DR   SUPFAM; SSF56235; SSF56235; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Autocatalytic cleavage; Complete proteome;
KW   Direct protein sequencing; Disease mutation; Disulfide bond;
KW   Glycoprotein; Hydrolase; Lysosome; Polymorphism; Protease;
KW   Reference proteome; Signal.
FT   SIGNAL        1     23       {ECO:0000244|PubMed:25944712,
FT                                ECO:0000269|PubMed:2011603}.
FT   CHAIN        24    205       Glycosylasparaginase alpha chain.
FT                                /FTId=PRO_0000002333.
FT   CHAIN       206    346       Glycosylasparaginase beta chain.
FT                                /FTId=PRO_0000002334.
FT   REGION      234    237       Substrate binding.
FT   REGION      257    260       Substrate binding.
FT   ACT_SITE    206    206       Nucleophile.
FT                                {ECO:0000269|PubMed:8846222}.
FT   MOD_RES      24     24       Blocked amino end (Ser).
FT   CARBOHYD     38     38       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:1281977,
FT                                ECO:0000269|PubMed:2401370,
FT                                ECO:0000269|PubMed:8846222}.
FT   CARBOHYD    308    308       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:8846222}.
FT   DISULFID     64     69       {ECO:0000269|PubMed:8846222}.
FT   DISULFID    163    179       {ECO:0000269|PubMed:8846222}.
FT   DISULFID    286    306       {ECO:0000269|PubMed:8846222}.
FT   DISULFID    317    345       {ECO:0000269|PubMed:8846222}.
FT   VARIANT      12     12       V -> L (in AGU; uncertain pathological
FT                                significance; dbSNP:rs74626221).
FT                                {ECO:0000269|PubMed:11309371}.
FT                                /FTId=VAR_015427.
FT   VARIANT      60     60       G -> D (in AGU; dbSNP:rs121964907).
FT                                /FTId=VAR_005069.
FT   VARIANT      72     72       S -> P (in AGU; specifically prevents the
FT                                proteolytic activation cleavage of AGA in
FT                                the endoplasmic reticulum;
FT                                dbSNP:rs121964909).
FT                                {ECO:0000269|PubMed:8776587}.
FT                                /FTId=VAR_005070.
FT   VARIANT     100    100       G -> E (in AGU; dbSNP:rs386833421).
FT                                {ECO:0000269|PubMed:9137882}.
FT                                /FTId=VAR_015428.
FT   VARIANT     101    101       A -> V (in AGU; dbSNP:rs121964908).
FT                                /FTId=VAR_005071.
FT   VARIANT     135    135       F -> S (in AGU; dbSNP:rs386833427).
FT                                {ECO:0000269|PubMed:9137882}.
FT                                /FTId=VAR_015429.
FT   VARIANT     149    149       T -> S (in dbSNP:rs2228119).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:1703489,
FT                                ECO:0000269|PubMed:1840528,
FT                                ECO:0000269|PubMed:1904874,
FT                                ECO:0000269|PubMed:2401370,
FT                                ECO:0000269|Ref.10, ECO:0000269|Ref.8}.
FT                                /FTId=VAR_033533.
FT   VARIANT     161    161       R -> Q (in AGU; dbSNP:rs192195150).
FT                                {ECO:0000269|PubMed:1703489,
FT                                ECO:0000269|PubMed:1904874,
FT                                ECO:0000269|PubMed:2011603}.
FT                                /FTId=VAR_005072.
FT   VARIANT     163    163       C -> S (in AGU; most frequent mutation;
FT                                abolishes autocatalytic cleavage and
FT                                enzyme activity; dbSNP:rs121964904).
FT                                {ECO:0000269|PubMed:1703489,
FT                                ECO:0000269|PubMed:1904874,
FT                                ECO:0000269|PubMed:2011603}.
FT                                /FTId=VAR_005073.
FT   VARIANT     252    252       G -> E (in AGU; dbSNP:rs386833433).
FT                                {ECO:0000269|PubMed:11309371}.
FT                                /FTId=VAR_015430.
FT   VARIANT     252    252       G -> R (in AGU; dbSNP:rs386833432).
FT                                {ECO:0000269|PubMed:11309371}.
FT                                /FTId=VAR_015431.
FT   VARIANT     257    257       T -> I (in AGU; dbSNP:rs386833434).
FT                                {ECO:0000269|PubMed:11309371}.
FT                                /FTId=VAR_015432.
FT   VARIANT     302    302       G -> R (in AGU; dbSNP:rs121964905).
FT                                /FTId=VAR_005074.
FT   VARIANT     306    306       C -> R (in AGU; dbSNP:rs121964906).
FT                                /FTId=VAR_005075.
FT   VARIANT     322    322       T -> I (in dbSNP:rs56849061).
FT                                /FTId=VAR_061026.
FT   CONFLICT     21     21       V -> A (in Ref. 4; AAB60655/CAA43958).
FT                                {ECO:0000305}.
FT   CONFLICT     25     25       S -> C (in Ref. 6; AA sequence).
FT                                {ECO:0000305}.
FT   STRAND       28     35       {ECO:0000244|PDB:1APY}.
FT   HELIX        37     48       {ECO:0000244|PDB:1APY}.
FT   HELIX        53     67       {ECO:0000244|PDB:1APY}.
FT   HELIX        69     71       {ECO:0000244|PDB:1APY}.
FT   STRAND       72     77       {ECO:0000244|PDB:1APY}.
FT   STRAND       87     93       {ECO:0000244|PDB:1APY}.
FT   TURN         94     96       {ECO:0000244|PDB:1APY}.
FT   STRAND       99    105       {ECO:0000244|PDB:1APY}.
FT   STRAND      107    109       {ECO:0000244|PDB:1APZ}.
FT   HELIX       111    121       {ECO:0000244|PDB:1APY}.
FT   STRAND      125    128       {ECO:0000244|PDB:1APY}.
FT   HELIX       129    138       {ECO:0000244|PDB:1APY}.
FT   HELIX       149    160       {ECO:0000244|PDB:1APY}.
FT   TURN        175    177       {ECO:0000244|PDB:1APY}.
FT   STRAND      207    212       {ECO:0000244|PDB:1APY}.
FT   STRAND      214    216       {ECO:0000244|PDB:1APZ}.
FT   STRAND      218    224       {ECO:0000244|PDB:1APY}.
FT   TURN        241    243       {ECO:0000244|PDB:1APY}.
FT   STRAND      244    248       {ECO:0000244|PDB:1APY}.
FT   TURN        249    251       {ECO:0000244|PDB:1APY}.
FT   STRAND      252    258       {ECO:0000244|PDB:1APY}.
FT   HELIX       260    263       {ECO:0000244|PDB:1APY}.
FT   HELIX       264    266       {ECO:0000244|PDB:1APY}.
FT   HELIX       268    277       {ECO:0000244|PDB:1APY}.
FT   HELIX       282    296       {ECO:0000244|PDB:1APY}.
FT   STRAND      302    308       {ECO:0000244|PDB:1APY}.
FT   STRAND      313    318       {ECO:0000244|PDB:1APY}.
FT   STRAND      325    331       {ECO:0000244|PDB:1APY}.
FT   TURN        333    335       {ECO:0000244|PDB:1APZ}.
FT   STRAND      339    344       {ECO:0000244|PDB:1APY}.
SQ   SEQUENCE   346 AA;  37208 MW;  766F1690B5B62FFA CRC64;
     MARKSNLPVL LVPFLLCQAL VRCSSPLPLV VNTWPFKNAT EAAWRALASG GSALDAVESG
     CAMCEREQCD GSVGFGGSPD ELGETTLDAM IMDGTTMDVG AVGDLRRIKN AIGVARKVLE
     HTTHTLLVGE SATTFAQSMG FINEDLSTTA SQALHSDWLA RNCQPNYWRN VIPDPSKYCG
     PYKPPGILKQ DIPIHKETED DRGHDTIGMV VIHKTGHIAA GTSTNGIKFK IHGRVGDSPI
     PGAGAYADDT AGAAAATGNG DILMRFLPSY QAVEYMRRGE DPTIACQKVI SRIQKHFPEF
     FGAVICANVT GSYGAACNKL STFTQFSFMV YNSEKNQPTE EKVDCI
//
